Covered recipient · General Payments record
BURTON J WISOTSKY
Allopathic & Osteopathic Physicians Ophthalmology
General Payments · PY2019–2024
$765.58
- Reported across 41 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $344.14 | 18 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| ABBVIE INC. | $214.57 | 11 |
| Dompe US, Inc. | $34.49 | 2 |
| Genentech USA, Inc. | $23.32 | 1 |
| BIOTISSUE HOLDINGS INC. | $20.80 | 1 |
| Alimera Sciences, Inc. | $19.42 | 1 |
| Harrow Eye, LLC | $16.70 | 1 |
| Mallinckrodt Hospital Products Inc. | $14.84 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (18)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $25.40 | 01/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106350402 | CMS |
| ABBVIE INC. | $18.05 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106350404 | CMS |
| ABBVIE INC. | $15.68 | 01/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106350406 | CMS |
| ABBVIE INC. | $25.54 | 02/09/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106350408 | CMS |
| ABBVIE INC. | $23.60 | 03/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106350410 | CMS |
| ABBVIE INC. | $17.10 | 03/11/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106350412 | CMS |
| ABBVIE INC. | $17.89 | 04/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106350414 | CMS |
| ABBVIE INC. | $17.62 | 05/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106350416 | CMS |
| ABBVIE INC. | $17.35 | 05/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106350418 | CMS |
| ABBVIE INC. | $18.88 | 06/06/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106350420 | CMS |
| ABBVIE INC. | $17.46 | 11/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1106350422 | CMS |
| Alimera Sciences, Inc. | $19.42 | 03/18/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1092835447 | CMS |
| BIOTISSUE HOLDINGS INC. | $20.80 | 01/08/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1148753140 | CMS |
| Dompe US, Inc. | $16.53 | 01/12/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151399122 | CMS |
| Dompe US, Inc. | $17.96 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1151399124 | CMS |
| Genentech USA, Inc. | $23.32 | 09/25/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1132983505 | CMS |
| Harrow Eye, LLC | $16.70 | 01/16/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145622539 | CMS |
| Mallinckrodt Hospital Products Inc. | $14.84 | 05/01/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1145153274 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2019, 2021, 2022, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.